Jeanette Weiland - Board Chair

Senior Vice President, Bio, Innovation & Special Projects at New Orleans Business Alliance. She previously served from 2015-2018 as a financial operations manager with Ochsner Health System’s retail division and as a system-wide administrative finance fellow. From 2009 to 2015, she was executive vice president of CIC Wealth, a Washington, D.C. investment advisory firm. Weiland began her finance career with the wealth advisory team at Capital One and USB Financial Services in New Orleans from 2006 to 2009 as a Series 7 and 66 license holder.

Her strong background in healthcare finance, financial management and business development allows her to step into the new role with deep-seated knowledge of the health and business community in New Orleans.

As the senior director of Bio Business & Strategy, Weiland will spearhead efforts to attract, retain, and expand businesses and investment while spurring job creation in the BioInnovation cluster in New Orleans.

Weiland is a certified Lean Six Sigma Greenbelt and has served on the board of several local nonprofits, including her current board position on the New Orleans Garden District Association. She earned a bachelor of science degree in International Trade and Finance at Louisiana State University. Additionally, Weiland holds a Masters of Arts in Arts Administration and a masters of business administration from The University of New Orleans.

Justin Hudman - Treasurer

Justin Hudman is a Senior Manager over State Affairs at Amgen. Before coming to Amgen Justin spent four years as the Division DIrector of Public Affairs for the Texas Pharmacy Association. Prior to that he has extensive experience on staff with the Texas Legislature.

He has a BA in Political Science and History from Texas A&M University - Kingsville. He is an experienced Director Of Public Affairs with a demonstrated history of working in the Hospital & Healthcare Industry, Skilled in Nonprofit Organizations, Political Communication, Public Affairs, Grassroots Organizing, and Government.

Lowry curley - CEO of Axosim

Lowry is co-founder and CEO of AxoSim. He drives the vision and implementation for product development and commercialization of AxoSim’s NerveSim® and BrainSim® drug discovery platforms, with the goal of making a significant impact on medicine and patient care. Lowry received a PhD in biomedical engineering from Tulane University focused on tissue engineering and neuroscience. He is active on HESI’s (Health and Environmental Science Institute) Neutox Committee, which is a national nonprofit that works to resolve global health and environmental challenges through engagement of scientists from academia, government, industry, NGOs, and other strategic partners.

Lowry is also an early member of the Nonclinical Innovation and Patient Safety Initiative collaboration (NIPSI) which advocates to the FDA for use of safer, more effective non-animal testing models in drug discovery. Locally, he serves on the New Orleans BioDistrict Board, dedicated to supporting economic growth of the biosciences sector in Southeast Louisiana.

Holly Turner

Holly Jacques Turner is a Director for the Merck State Government Affairs and Policy Division. In this role, Holly oversees all legislative and regulatory work for Merck in Louisiana, Oklahoma and Texas.

Before joining Merck in 1997, Holly was the Director of Health Policy for Texas Lieutenant Governor Bob Bullock.

Trivia Frazier - CEO of Obatala Sciences

Dr. Frazier has over 15 years of training and research experience in the isolation, culture, expansion, and characterization of adherent stromal/stem cells from adipose tissue and bone marrow. She has been in various management positions for the past 7 years. Dr. Frazier completed her undergraduate training in physics and biomedical engineering through a dual degree program between Tulane University and Dillard University, a historically black private university in New Orleans, and her graduate training in the Biomedical Science Program at Tulane University School of Medicine. In 2013, Dr. Frazier began working as a post-doctoral fellow with Dr. Jeffrey Gimble on an NIH R21 project entitled ‘Distinguishing adipose stromal vs. stem cells by serial transplantation’.

During this work, she combined murine SVF cells with a silk scaffold to create a tissue engineered fat pad for in vitro and in vivo studies. She held a tenure-track appointment as Assistant Professor in the Department of Physics at Dillard University until 2016 and served as the department Chair. Dr. Frazier then served as the NSF Project Director for proof of concept and commercialization of work supported by an NSF Phase I SBIR, entitled: ‘Tissue Engineered Human “Fat on a Chip”: A Novel Tool for Metabolic Drug Discovery’. Dr. Frazier obtained her MBA from the executive program in the Tulane University Freeman School of Business, class of 2018, and finished in the top 10% of her class.

Kyle Kamrath - Vertex

Kyle is the State Government Affairs Manager at Vertex Pharmaceuticals. He has an accomplished career formerly as a Policy Advisor to the Governor of Texas, Government Affairs for the Texas Apartment Association. He has also served in various political consultant and advisor roles to elected officials across the region.

Glenn Anderson - Dean: ULM School of Pharmacy

Glenn Anderson is an alumnus, husband, father, faculty member, and an administrator. He completed his education at The Ohio State University -- BS Pharm (1991), PharmD (1994), and fellowship (1996). He began his career at Texas Tech University serving as faculty (1996-2011), drug information center director (1996 – 2002), clinical pharmacist (2002-2006), and Associate Dean (2005-2011).

In 2011, Dr. Anderson help launch the Marshall University School of Pharmacy in Huntington, WV. He served as the School's Associate Dean until August 2017. He current serves as the University of Louisiana Monroe's Dean for the College of Health and Pharmaceutical Sciences.